These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12923431)

  • 21. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
    Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Storb R
    Transplantation; 1994 Feb; 57(3):423-6. PubMed ID: 8108879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canine CD4(+)CD8(+) double-positive T cells can develop from CD4(+) and CD8(+) T cells.
    Bismarck D; Moore PF; Alber G; von Buttlar H
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):72-82. PubMed ID: 25454082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.
    Georges GE; Storb R; Bruno B; Brodie SJ; Thompson JD; Taranova AG; Zaucha JM; Little MT; Zellmer E; Moore PF; Gooley T; Sale G; Kiem HP; Sandmaier BM; Lyons RM; Nash RA
    Blood; 2001 Dec; 98(12):3447-55. PubMed ID: 11719387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of CD6-depleted peripheral blood stem cells after DLA-haploidentical bone marrow transplantation contributes to engraftment and tolerance in a preclinical model of stem cell transplantation.
    Zorn J; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):27-35. PubMed ID: 21784536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine CD4+CD8+ double positive T cells in peripheral blood have features of activated T cells.
    Bismarck D; Schütze N; Moore P; Büttner M; Alber G; Buttlar Hv
    Vet Immunol Immunopathol; 2012 Oct; 149(3-4):157-66. PubMed ID: 22789871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin?
    Deeg HJ; Pierpaoli W; Arrighi S; Seidel K; Graham T; Huss R; Yu C; Myerson D; Schuening F; Storb R
    Transpl Immunol; 1996 Jun; 4(2):113-6. PubMed ID: 8843587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization".
    Nakaya A; Qiu H; Santos EB; Hamlin DK; Wilbur DS; Storb R; Sandmaier BM
    Transplant Cell Ther; 2021 Jun; 27(6):476.e1-476.e7. PubMed ID: 33775618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+/DR+/CD25--T-lymphocytes associated with marrow graft failure.
    Voltarelli JC; Przepiorka D; Shankar P; Kopecky K; Martin PJ; Torok-Storb B
    Bone Marrow Transplant; 1989 Nov; 4(6):647-52. PubMed ID: 2573398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
    Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment.
    Storb R; Raff RF; Deeg HJ; Graham TC; Schuening FG; Shulman H; Bryant E
    Transplantation; 1995 May; 59(10):1481-2. PubMed ID: 7770937
    [No Abstract]   [Full Text] [Related]  

  • 38. Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.
    Deeg HJ; Storb R; Thomas ED
    Surv Immunol Res; 1982; 1(2):148-54. PubMed ID: 6764839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 and CD8 T cell response to the rHSP60 from Klebsiella pneumoniae in peripheral blood mononuclear cells from patients with ankylosing spondylitis.
    Zambrano-Zaragoza F; García-Latorre E; Domínguez-López ML; Cancino-Díaz ME; Burgos-Vargas R; Jiménez-Zamudio L
    Rev Invest Clin; 2005; 57(4):555-62. PubMed ID: 16315640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
    Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.